Trial intelligence / Profile preview

Bimatoprost 0.3 mg/ml eye drops for eyelash lengthening – pilot study

2014-002553-19Phase 3Completed

Sponsor: Medical University of Graz
Start: Oct 2014
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries: 1

Overview

Phase 3, single-arm trial of bimatoprost in eyelash hypotrichosis, sponsored by Medical University of Graz. Primary endpoint: Efficacy of bimatoprost for eyelash lengthening. Started Oct 2014; status: completed.

Drugs

bimatoprost

Conditions

eyelash hypotrichosis

Beyond the preview

Go deeper on 2014-002553-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-002553-19.